Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Apraxia

3,4-methylenedioxyamphetamine has been researched along with Apraxia in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research Excerpts

ExcerptRelevanceReference
"A survey was sent to members of the Dyspraxia Support Group of New Zealand asking participants to prioritise the three factors that had most positively and negatively influenced the development of the young person's SE."1.56Coordination difficulties and self-esteem: The views of children, adolescents, and their parents. ( Eggleston, M; Frampton, C; Hanger, N; Watkins, W, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Eggleston, M1
Watkins, W1
Frampton, C1
Hanger, N1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Apraxia

ArticleYear
Coordination difficulties and self-esteem: The views of children, adolescents, and their parents.
    Australian occupational therapy journal, 2020, Volume: 67, Issue:5

    Topics: Adolescent; Apraxias; Child; Family Relations; Female; Humans; Love; Male; Motor Skills Disorders; N

2020